NCT04693741
Xenografts With Platelet-rich Fibrin Versus Autogenous Bone in Alveolar Cleft Grafting
Xenografts With Platelet-rich Fibrin Versus Autogenous Bone in Alveolar Cleft Grafting: A Comparative Clinical Study
Assiut University·ClinicalTrials.gov·procedureNot yet recruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Alveolar Cleft
- Drug/Device/Intervention
- secondary alveolar bone graft
- Study type
- Interventional
- Intervention type
- procedure
Sponsor & location
- Primary sponsor
- Assiut University
Timeline & enrollment
- Phase
- N/A
- Start date
- Jan 01, 2021
- End date
- Mar 01, 2023
- Enrollment
- 36 participants
Primary outcome
measuring of bone volume 6 months post-operative.
Summary
this work aims to evaluate xenografts mixed with PRF versus autogenous bone graft in alveolar
 cleft grafting.
ICD-10 classifications
Cleft palateCleft palate, unspecifiedCleft soft palateOther branchial cleft malformationsCleft uvula
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT04693741
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for NCT04693741 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Not yet recruiting. The study focuses on Alveolar Cleft. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.